Data analytics provider Health Catalyst sets terms for $129 million IPO

Shutterstock photo

Health Catalyst, which provides a data analytics platform and services to healthcare organizations, announced terms for its IPO on Friday.

The Salt Lake City, UT-based company plans to raise $129 million by offering 6 million shares at a price range of $20 to $23. At the midpoint of the proposed range, Health Catalyst would command a fully diluted market value of $826 million.

Health Catalyst was founded in 2008 and booked $127 million in sales for the 12 months ended March 31, 2019. It plans to list on the Nasdaq under the symbol HCAT. Goldman Sachs, J.P. Morgan and William Blair are the joint bookrunners on the deal. It is expected to price during the week of July 22, 2019.

The article Data analytics provider Health Catalyst sets terms for $129 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital


Research Brokers before you trade

Want to trade FX?